Target intelligence / Profile preview

Cation-chloride cotransporter (SLC12 family) (CCC)

Target
CCC
Molecular classification
Transporter, Solute carrier family (SLC12), Ion transporter
01

Overview

Cation-chloride cotransporters (CCCs), primarily members of the solute carrier family 12 (SLC12), are integral membrane proteins that facilitate the electroneutral movement of chloride ions coupled with sodium and/or potassium across cell membranes. This family includes the sodium-potassium-chloride cotransporters (NKCC1 and NKCC2), the sodium-chloride cotransporter (NCC), and the potassium-chloride cotransporters (KCC1-4). These transporters are essential for maintaining ionic homeostasis, regulating cell volume, and managing transepithelial salt transport, particularly in the kidneys and the nervous system. In the kidney, NKCC2 and NCC are the primary sites of action for loop and thiazide diuretics, respectively, which are cornerstone treatments for hypertension and edema. In the brain, the balance of chloride transport by NKCC1 and KCC2 is crucial for establishing the chloride gradient necessary for effective GABAergic inhibition. Dysregulation of these transporters is implicated in various pathologies, including cardiovascular diseases, epilepsy, and genetic salt-wasting syndromes like Bartter and Gitelman syndromes.

Other names
SLC12 familyCation-chloride cotransporterElectroneutral cation-chloride cotransporterNKCC (Sodium-potassium-chloride cotransporter)NCC (Sodium-chloride cotransporter)KCC (Potassium-chloride cotransporter)
02

Mechanism of action

Inhibition of cation-coupled chloride transport in the renal tubule, leading to increased excretion of electrolytes and water (diuresis), or modulation of neuronal chloride gradients to influence inhibitory neurotransmission.

03

Biological functions

Transepithelial ion transportCell volume regulationMaintenance of intracellular chloride concentrationRegulation of blood pressure and fluid balanceModulation of neuronal excitability
04

Disease associations

HypertensionEdemaBartter syndromeGitelman syndromeEpilepsyNeuropathic pain
05

Safety considerations

Electrolyte imbalances (hypokalemia, hyponatremia)DehydrationOtotoxicityHyperuricemia
06

Interacting drugs

Furosemide

7 more in the full profile.

07

Biomarkers

Serum potassium levelsSerum sodium levelsBlood pressureUrinary electrolyte excretion

Beyond the preview

Go deeper on Cation-chloride cotransporter (SLC12 family) (CCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cation-chloride cotransporter (SLC12 family) (CCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call